How can quality of life researchers make their work more useful to health workers and their patients?

Quality of Life Research

Volumn 16, Issue 7, 2007, Pages 1097-1105

  Guyatt, Gordon ^a   Schunemann, Holger ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Decision aids; Minimal important difference; Number needed to treat; Systematic reviews

Indexed keywords

CLINICAL DECISION MAKING; HEALTH CARE PERSONNEL; HUMAN; INFORMATION RETRIEVAL; MEDICAL RESEARCH; PATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

DECISION SUPPORT SYSTEMS, CLINICAL; DECISION SUPPORT TECHNIQUES; HEALTH PERSONNEL; HEALTH SERVICES RESEARCH; HEALTH STATUS INDICATORS; HUMANS; META-ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PROFESSIONAL-PATIENT RELATIONS; QUALITY OF LIFE;

EID: 34548413580     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-007-9223-3     Document Type: Review

References (48)

1. Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schunemann, H. (2006). Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American college of chest physicians task force. Chest, 129, 174-181.
2. Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002). Methods to explain the clinical significance of health status measures. Mayo Clin Proc, 77, 371-383.
3. Schunemann, H. J., Akl, E. A., & Guyatt, G. H. (2006). Interpreting the results of patient reported outcome measures in clinical trials: The clinician's perspective. Health Qual Life Outcomes, 4, 62.
4. Brozek, J. L., Guyatt, G. H., & Schunemann, H. J. (2006). How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health Qual Life Outcomes, 4, 69.
5. Gary, R. (2006). Exercise self-efficacy in older women with diastolic heart failure: results of a walking program and education intervention. J Gerontol Nurs, 32, 31-39, quiz 40-1.
6. Naunheim, K. S., Wood, D. E., Mohsenifar, Z., Sternberg, A. L., Criner, G. J., DeCamp, M. M., Deschamps, C. C., Martinez, F. J., Sciurba, F. C., Tonascia, J., & Fishman, A. P. (2006). Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg, 82, 431-443.
7. Burns, J., Crosbie, J., Ouvrier, R., & Hunt, A. (2006). Effective orthotic therapy for the painful cavus foot: A randomized controlled trial. J Am Podiatr Med Assoc, 96, 205-211.
8. Broderick, J. E., Junghaenel, D. U., & Schwartz, J. E. (2005). Written emotional expression produces health benefits in fibromyalgia patients. Psychosom Med, 67, 326-334.
9. Mui, W. L., Ng, C. S., Fung, T. M., Cheung, F. K., Wong, C. M., Ma, T. H., Bn, M. Y., & Ng, E. K. (2006). Prophylactic ilioinguinal neurectomy in open inguinal hernia repair: A double-blind randomized controlled trial. Ann Surg, 244, 27-33.
10. Wong, R. K., Paul, N., Ding, K., Whitehead, M., Brundage, M., Fyles, A., Wilke, D., Nabid, A., Fortin, A., Wilson, D., McKenzie, M., Ackerman, I., Souhami, L., Chabot, P., & Pater, J. (2006). 5-Hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: A placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). J Clin Oncol, 24, 3458-3464.
11. Weaver, A. L., Messner, R. P., Storms, W. W., Polis, A. B., Najarian, D. K., Petruschke, R. A., Geba, G. P., & Tershakovec, A. M. (2006). Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone. J Clin Rheumatol, 12, 17-25.
12. Bacigalupo, A., Lamparelli, T., Barisione, G., Bruzzi, P., Guidi, S., Alessandrino, P. E., di Bartolomeo, P., Oneto, R., Bruno, B., Sacchi, N., van Lint, M. T., & Bosi, A. (2006). Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: Long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant, 12, 560-565.
13. Forrow, L., Taylor, W. C., & Arnold, R. M. (1992). Absolutely relative: How research results are summarized can affect treatment decisions. Am J Med, 92, 121-124.
14. Naylor, C. D., Chen, E., & Strauss, B. (1992). Measured enthusiasm: Does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med, 117, 916-921.
15. Malenka, D. J., Baron, J. A., Johansen, S., Wahrenberger, J. W., & Ross, J. M. (1993). The framing effect of relative and absolute risk. J Gen Intern Med, 8, 543-548.
16. Kosinski, M., Zhao, S. Z., Dedhiya, S., Osterhaus, J. T., & Ware, J. E. Jr. (2000). Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum, 43, 1478-1487.
17. Kulkarni, A. V. (2006). Distribution-based and anchor-based approaches provided different interpretability estimates for the Hydrocephalus Outcome Questionnaire. J Clin Epidemiol, 59, 176-184.
18. Coeytaux, R. R., Kaufman, J. S., Chao, R., Mann, J. D., & Devellis, R. F. (2006). Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in Headache Impact Test. J Clin Epidemiol, 59, 374-380.
19. Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials, 10, 407-415.
20. Deyo, R. A., & Inui, T. S. (1984). Toward clinical applications of health status measures: Sensitivity of scales to clinically important changes. Health Serv Res, 19, 275-289.
21. Thompson, M. S., Read, J. L., Hutchings, H. C., Paterson, M., & Harris, E. D. Jr. (1988). The cost effectiveness of auranofin: Results of a randomized clinical trial. J Rheumatol, 15, 35-42.
22. Fergusson, D., Aaron, S. D., Guyatt, G., & Hebert, P. (2002). Post-randomisation exclusions: The intention to treat principle and excluding patients from analysis. Bmj, 325, 652-654.
23. Furukawa, T. (1999). From effect size into number needed to treat. Lancet, 353, 1680.
24. Brooks, W. B., Jordan, J. S., Divine, G. W., Smith, K. S., & Neelon, F. A. (1990). The impact of psychologic factors on measurement of functional status. Assessment of the sickness impact profile. Med Care, 28, 793-804.
25. Fletcher, A., McLoone, P., & Bulpitt, C. (1988). Quality of life on angina therapy: A randomised controlled trial of transdermal glyceryl trinitrate against placebo. Lancet, 2, 4-8.
26. King, T. K., Ali, N., & Briscoe, W. A. (1973). Treatment of hypoxia with 24 percent oxygen. A new approach to the interpretation of data collected in a pulmonary intensive care unit. Am Rev Respir Dis, 108, 19-29.
27. Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981). The Sickness Impact Profile: Development and final revision of a health status measure. Med Care, 19, 787-805.
28. Ware, J. E. Jr., Manning, W. G. Jr., Duan, N., Wells, K. B., & Newhouse, J. P. (1984). Health status and the use of outpatient mental health services. Am Psychol, 39, 1090-1100.
29. Mossey, J. M., & Shapiro, E. (1982). Self-rated health: A predictor of mortality among the elderly. Am J Public Health, 72, 800-808.
30. Idler, E. L., & Angel, R. J. (1990). Self-rated health and mortality in the NHANES-I Epidemiologic Follow-up Study. Am J Public Health, 80, 446-452.
31. Brook, R. H., Ware, J. E. Jr., Rogers, W. H., Keeler, E. B., Davies, A. R., Donald, C. A., Goldberg, G. A., Lohr, K. N., Masthay, P. C., & Newhouse, J. P. (1983). Does free care improve adults' health? Results from a randomized controlled trial. N Engl J Med, 309, 1426-1434.
32. Goldstein, R. S., Todd, T. R., Guyatt, G., Keshavjee, S., Dolmage, T. E., van Rooy, S., Krip, B., Maltais, F., LeBlanc, P., Pakhale, S., & Waddell, T. K. (2003). Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease. Thorax, 58, 405-410.
33. Goldstein, R. S., Gort, E. H., Stubbing, D., Avendano, M. A., & Guyatt, G. H. (1994). Randomised controlled trial of respiratory rehabilitation. Lancet, 344, 1394-1397.
34. Guyatt, G. H., Juniper, E. F., Walter, S. D., Griffith, L. E., & Goldstein, R. S. (1998). Interpreting treatment effects in randomised trials. Bmj, 316, 690-693.
35. Derose, K., Kanouse, D., Weidmer, B., Weech-Maldonado, R., Garcia, R., & Hays, R. (in press). Developing a Spanish-language sample report for CAHPS. Joint Commission Journal on Quality and Patient Safety.
36. Burge, P. S., Calverley, P. M., Jones, P. W., Spencer, S., Anderson, J. A., & Maslen, T. K. (2000). Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial. Bmj, 320, 1297-1303.
37. Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care, 41, 582-592.
38. Norman, G. R., Sridhar, F. G., Guyatt, G. H., & Walter, S. D. (2001). Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care, 39, 1039-1047.
39. Supina, A. L., Feeny, D. H., Carroll, L. J., & Johnson, J. A. (2006). Misinterpretation with norm-based scoring of health status in adults with type 1 diabetes. Health Qual Life Outcomes, 4, 15.
40. Guyatt, G., Hayward, R., Richardson, W. S., Green, L., Wilson, M., Sinclair, J., Cook, D., Glasziou, P., Detsky, A., & Bass, E. (2002). Moving from evidence to action. In G. R. Guyatt & D. Rennie (Eds.), The Users' Guides to the Medical Literature: A Manual for Evidence-based Clinical Practice. Chicago, Illinois: AMA publications.
41. Oxman, A., Guyatt, G., Jaeschke, R., Montori, V. (2002). Summarizing the evidence. In G. R. Guyatt & D. Rennie (Eds.), The Users' Guides to the Medical Literature: A Manual for Evidence-based Clinical Practice. Chicago, Illinois: AMA publications.
42. Cohen, J. (1988). Statistical power analysis in the behavioral sciences. Hillsdale, NJ: Erlbaum.
43. Lacasse, Y., Wong, E., Guyatt, G. H., King, D., Cook, D. J., & Goldstein, R. S. (1996). Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet, 348, 1115-1119.
44. Charles, C., Whelan, T., & Gafni, A. (1999). What do we mean by partnership in making decisions about treatment? Bmj, 319, 780-782.
45. Guyatt, G. H., Haynes, R. B., Jaeschke, R. Z., Cook, D. J., Green, L., Naylor, C. D., Wilson, M. C., & Richardson, W. S. (2000). Users' Guides to the Medical Literature: XXV. Evidence-based medicine: Principles for applying the Users' Guides to patient care. Evidence-based Medicine Working Group. Jama, 284, 1290-1296.
46. O'Connor, A. M., Legare, F., & Stacey, D. (2003). Risk communication in practice: The contribution of decision aids. Bmj, 327, 736-740.
47. Whelan, T. J., & Loprinzi, C. (2005). Physician/patient decision aids for adjuvant therapy. J Clin Oncol, 23, 1627-1630.
48. Akl, E. A., Grant, B. J. B., Guyatt, G. H., Montori, V. M., & Schünemann, H. J. (in press). A decision aid for COPD patients considering inhaled steroid therapy: development and before and after pilot testing. BMC Med Inform Decis Making.